Brief: Collplant Announces Development And Global Commercialization Agreement With Allergan Aesthetics

Collplant Biotechnologies

08/02/2021 12:19

Feb 8 (Reuters) - Collplant Biotechnologies Ltd  CPTGy.F :
    * COLLPLANT ANNOUNCES DEVELOPMENT AND GLOBAL
COMMERCIALIZATION
AGREEMENT WITH ALLERGAN AESTHETICS, AN ABBVIE COMPANY, FOR
RHCOLLAGEN IN DERMAL AND SOFT TISSUE FILLER PRODUCTS
    * COLLPLANT BIOTECHNOLOGIES - ALLERGAN AESTHETICS HAS RIGHT
OF
FIRST NEGOTIATION FOR CO'S TECHNOLOGY IN 2 FUTURE ADDITIONAL
PRODUCTS
    * COLLPLANT BIOTECHNOLOGIES - WILL RECEIVE UPFRONT PAYMENT
OF $14
MILLION, IS ENTITLED TO RECEIVE UPTO ADDITIONAL $89 MILLION IN
MILESTONE PAYMENTS
    * COLLPLANT BIOTECHNOLOGIES - ELIGIBLE TO RECEIVE ROYALTY
PAYMENTS
& A FEE FOR MANUFACTURE AND SUPPLY OF RHCOLLAGEN TO ALLERGAN
AESTHETICS

Source text for Eikon:  ID:nPnchjrpxa 
Further company coverage:  CPTGy.F 

 ((Reuters.Briefs@thomsonreuters.com;))